New Recipe for Powerful Stem Cells Promises Greater Insight: Scientific American

New Recipe for Powerful Stem Cells Promises Greater Insight: Scientific American: "A Massachusetts company announced today that it has grown large numbers of a rare type of human embryonic stem cell that can transform into blood and blood vessels. When injected into mice, the cells congregated around damaged blood vessels in the eye, heart and limbs, where they seemed to help rebuild injured tissue, according to a report published online today. The company says it plans to request approval by the end of next year to conduct human trials of the cells, called hemangioblasts."

Chemical & Engineering News: Cover Story - Sowing Seeds Of Cures

Chemical & Engineering News: Cover Story - Sowing Seeds Of Cures: "As venture capitalists' priorities shift, venture philanthropists fill the gap in funding of drug discovery by biotechs"

Biotech Blog � Indian biotechnology: Full of promise, challenged by patents

Biotech Blog � Indian biotechnology: Full of promise, challenged by patents: "India’s biotechnology industry has the potential to become a major driver of the country’s economy, but is challenged by one vital omission: patent protection. "

Health Business Blog � Blog Archive � Credibility and prosperity in biotech

Health Business Blog � Blog Archive � Credibility and prosperity in biotech: "I want the biotechnology industry to prosper. I don’t object to the concept of drugs that are priced at $100,000 per year, though I realize that explaining that kind of cost to the public can be hard.

So, biotech industry, let me make a suggestion, which I hope you’ll take in the right way: You shouldn’t exaggerate the truth to get your point across. It could come back to bite you.

What am I talking about?"

The Blog That Ate Manhattan: Grand Rounds, Volume 3, No 33

The Blog That Ate Manhattan: Grand Rounds, Volume 3, No 33: "Welcome to Grand Rounds, a carnival of posts submitted by medical bloggers every week. It's the best of the medical blogosphere, and I am privileged to host this week.
"

UCSF Today - Universities, Not Companies, Drive Biotech Advancement

UCSF Today - Universities, Not Companies, Drive Biotech Advancement: "A study by Marks & Clerk, an intellectual property firm based in the United Kingdom, has found that during the period between 2002 and 2006, universities like UCSF and public research institutes, rather than private companies, drove advances in biotechnology."

News from Canadian Biopharma

News from Canadian Biopharma: "At the beginning of this year, in a special forecast issue, Canadian Business news magazine (December 25 – January 14, 2007) advised us of some exciting new developments in the Canadian life-sciences industry pipeline. Four companies in particular were named, because of their late-phase clinical trials and expected regulatory approval in several countries. I checked into these four companies to get an update of where they are four months later."